Finance

Lists
Why is CUE down ७.७८%?
Dive Deeper
CUE:NASDAQ
Cue Biopharma Inc
US$ ४.१५
-७.७८%
(-०.३५) 1D
US$ ४.२०
+१.२०% (+०.०५०)
After hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
US$ ४.५२
High
US$ ४.९०
Low
US$ ४.०५
Mkt. cap
३.४७ करोड
Avg. vol.
८.०३ लाख
Volume
१२.६३ लाख
52-wk high
US$ ४५.५०
52-wk low
US$ २.८३
EPS
-US$ २६.९९
Beta
२.७९
Shares outstanding
८३.६० लाख
No. of employees
२९
Open
US$ ४.५२
High
US$ ४.९०
Low
US$ ४.०५
Mkt. cap
३.४७ करोड
Avg. vol.
८.०३ लाख
Volume
१२.६३ लाख
52-wk high
US$ ४५.५०
52-wk low
US$ २.८३
EPS
-US$ २६.९९
Beta
२.७९
Shares outstanding
८३.६० लाख
No. of employees
२९
News stories
From web sources and news partners
About Cue Biopharma Inc
CEO-
Employees२९
Founded२०१४
Headquartersबोस्टन, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to CUE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CUE in the last 3 months.
Highest
Current US$ ४.१५
US$ २५.०० (+५०२.४१%)
Average
US$ २५.०० (+५०२.४१%)
Lowest
US$ २५.०० (+५०२.४१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$ २५.००
+५०२.४%
11/18/2026
Dev Prasad
Lucid Capital
Buy
Maintained
-
-
11/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
२.१९ करोड
५६.८६ लाख
७८.७७ लाख
१.३२ लाख
Cost of goods sold
१.५९ करोड
६३.९७ लाख
४.८५ करोड
-
Cost of revenue
१.५९ करोड
६३.९७ लाख
४.८५ करोड
-
Research and development expenses
-
-
-
१.७० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४०.५२ लाख
४६.५२ लाख
४.७१ करोड
२.९८ करोड
Operating expense
४०.५२ लाख
४६.५२ लाख
४.७१ करोड
४.६८ करोड
Total operating expenses
२.०० करोड
१.१० करोड
९.५६ करोड
४.६८ करोड
Operating income
१९.५८ लाख
-५३.६३ लाख
-८.७७ करोड
-४.६७ करोड
Other non operating income
-
-
-६.५५ करोड
-३८.९८ लाख
EBT including unusual items
२०.८५ लाख
-५१.७८ लाख
-१५.३१ करोड
-५.०० करोड
EBT excluding unusual items
२०.६५ लाख
-५१.८८ लाख
-१५.३१ करोड
-५.०१ करोड
Income tax expense
५.०० लाख
-
-
-
Effective tax rate
२३.९८%
-
-
-
Other operating expenses
-
-
-
-
Net income
१५.८५ लाख
-५१.७८ लाख
-१५.३१ करोड
-५.०० करोड
Net profit margin
७.२२%
-९१.०७%
-१,९४३.२१%
-३७,८९०.९१%
Earnings per share
-
-
-
-
Interest and investment income
१.५८ लाख
१.७९ लाख
१.५७ लाख
४.८३ लाख
Interest expense
-५१.०० हजार
-४.०० हजार
-५.०० हजार
-२.०० हजार
Net interest expenses
१.०७ लाख
१.७५ लाख
१.५२ लाख
४.८१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
२६.३६ लाख
-४७.९७ लाख
-८.७७ करोड
-४.६७ करोड
Gain or loss from assets sale
-२०.०० हजार
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू